Recombinant Human Papillomavirus Vaccine (types 6,11,16,18,31,33,45,52,58) (E. coli expression)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Papillomavirus Vaccine (types 6,11,16,18,31,33,45,52,58) (E. coli expression), covering 2021-04-08 to 2021-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) [Phase 2]